ARTICLE | Company News
Glaxo takes further PowderJect license
March 21, 2000 8:00 AM UTC
Glaxo Wellcome (LSE:GLX; GLXO) will buy from PowderJect (LSE:PJP) another DNA vaccine license for PJP's needle-free drug delivery technology under the companies' 1998 collaboration. GLX will use the t...